Andros Pharmaceuticals Co.,Ltd (TPEX:6917)
Taiwan · Delayed Price · Currency is TWD 32.10
-1.05 (-3.17%)
Oct 30, 2026, 1:26 PM CST
TPEX:6917 Market Cap
TPEX:6917 has a market cap or net worth of 1.46 billion as of October 30, 2026. It is the 30,881st most valuable company in the world and the 1,833rd biggest in Taiwan. Its market cap has increased by 67.10% in one year.
Market Cap
1.46B
Enterprise Value
n/a
Revenue
n/a
Global Rank
Country Rank
#1,833 Taiwan
PE Ratio
n/a
ChartMarket Cap Chart
Since January 12, 2023, TPEX:6917's market cap has increased from 1.11B to 1.46B, an increase of 31.50%. That is a compound annual growth rate of 7.47%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 30, 2026 | 1.46B | 32.72% |
| Dec 31, 2025 | 1.10B | 43.17% |
| Dec 31, 2024 | 770.08M | -30.92% |
| Dec 29, 2023 | 1.11B | 0.19% |
| Jan 12, 2023 | 1.11B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| G&E Herbal Biotechnology | 1.86B |
| U-Neuron Biomedical | 1.72B |
| Anti-Microbial Savior BioteQ | 1.71B |
| Sunny Pharmtech | 1.64B |
| Synbio Tech | 1.61B |
| Greenyn Biotechnology | 1.57B |
| GenMont Biotech Incorporation | 1.47B |
| Advagene Biopharma | 1.43B |